Physician profile

Saeed Payvar

Cardiovascular Disease · Mount Airy, NC

NPI 1134339104

$40,479.94

in general payments reported to CMS, 2019-2025

38 companies · $16K in 2025

The $16K reported for 2025 was more than what 96% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).

See the full distribution for Cardiovascular Disease

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Travel and Lodging$24,085.49
Food and Beverage$5,318.27

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Medtronic, INC. $21,800.69 2021-2025 In.Pact Admiral, Symplicity G3, Abre
Bard Peripheral Vascular, INC. $3,546.59 2019-2023 Rotarexs 6 F X 135 Cm
Cms Imaging, INC. $2,973.63 2025
Abbott Laboratories $2,626.89 2019-2025 Optis, Xience Skypoint, Diamondback Peripheral
Cardiovascular Systems INC. $1,908.22 2019-2022
Ekos Corporation $1,376.37 2019
Boston Scientific Corporation $1,060.11 2021-2025 Watchman Access System, Varithena Administration Pack, Express Ld Iliac / Biliary
Cook Incorporated $931.18 2021
Philips North America LLC $641.62 2022-2025 Igt Devices Systems Undivided, Labosys, Encore
Shockwave Medical, INC $591.43 2019-2022
Cook Medical LLC $461.12 2019-2024 Zilver Ptx
Merit Medical Systems INC $323.92 2021
Inari Medical, INC. $310.66 2024 Flowtriever Catheter, S, Ct Thrombectomy System Kit
Amgen INC. $269.83 2022-2025 Repatha, Repatha
Baxter Healthcare $246.55 2022-2023 Hillrom - Cardiac Ambulatory Monitor
Show all 38 companies
CompanyGeneral paymentsYearsTop products
Impulse Dynamics (USA) INC. $238.18 2023 Optimizer
E.R. Squibb & Sons, L.L.C. $160.89 2022-2025 Camzyos, Eliquis
Medtronic Vascular, INC. $158.72 2020
Heartflow, INC. $149.05 2022-2025 Ffrct
Pfizer INC. $82.62 2022-2025
Novartis Pharmaceuticals Corporation $74.68 2021-2024
Esperion Therapeutics, INC. $66.21 2022-2023 Nexletol
Cvrx, INC. $64.12 2023-2024 Barostim Neo System
Merck Sharp & Dohme LLC $50.48 2022
Surmodics, INC. $50.15 2022
Novo Nordisk INC $48.92 2024 Rybelsus, Ozempic
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $40.63 2022-2023 Lifevest
Janssen Pharmaceuticals, INC $30.78 2021-2022
Atricure, INC. $29.75 2023-2024
Getinge USA Sales, LLC $25.20 2019-2020
Kiniksa Pharmaceuticals, LTD. $21.32 2023 Arcalyst
Irhythm Technologies, INC. $20.21 2019
Bardy Diagnostics, INC. $19.00 2022
Tactile Systems Technology INC $18.60 2025 Nimbl, Flexitouch Plus
Kerecis Limited $18.46 2023 Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen
Organogenesis INC. $16.59 2022
Angiodynamics, INC. $15.37 2024 Alphavac
Ossur Americas, INC. $11.20 2024

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Saeed Payvar

$40,479.94

in general payments reported 2019-2025

Years
2019-2025
Top company
Medtronic, INC.
Context
The $16K reported for 2025 was more than what 96% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).

https://glasscript.com/doctor/277934/saeed-payvar

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.